Reuters logo
3 个月前
BRIEF-Myriad Genetics announced new data "demonstrating utility" of prolaris test
2017年5月12日 / 上午11点29分 / 3 个月前

BRIEF-Myriad Genetics announced new data "demonstrating utility" of prolaris test

May 12 (Reuters) - Myriad Genetics Inc:

* Myriad Genetics - announced new data "demonstrating utility" of prolaris test to predict 10-year risk of metastases in men treated for prostate cancer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below